Clopilet-A 75, Aspirin + Clopidogrel, Lifestyle-related Diseases, Cerebral Infarction & Myocardial Infarction, Online Pharmacy

Clopilet-A 75 Capsule

★★★★★

(0)

Generic For	DUOCOVERA
Active Ingredient	ASPIRIN\|CLOPIDOGREL
Strength	75MG\|75MG
Manufacturer	SUN PHARMACEUTICALS

Pack Size	Price Per Unit	Unit Price	Best Coupon Price MAX DISCOUNT
★ Best Value 1 BOX - 100 CAPSULES	$ 0.33	$ 32.90	$ 27.97 Apply ZARVY26 (-15%) You save $ 4.94
★ Best Value 2 BOXES - 200 CAPSULES	$ 0.29	11% $ 65.80 $ 58.80	$ 49.98 Apply ZARVY26 (-15%) You save $ 8.82
★ Best Value 3 BOXES - 300 CAPSULES	$ 0.28	16% $ 98.70 $ 82.90	$ 70.47 Apply ZARVY26 (-15%) You save $ 12.44

Pack Size

Price Per Unit

Unit Price

QTY

CART

Best Coupon Price
MAX DISCOUNT

1 BOX - 100 CAPSULES

$ 0.33

$ 32.90

$ 27.97

Apply ZARVY26 (-15%)

You save $ 4.94

2 BOXES - 200 CAPSULES

$ 0.29

11% $ 65.80

$ 58.80

$ 49.98

Apply ZARVY26 (-15%)

You save $ 8.82

★ Best Value 3 BOXES - 300 CAPSULES

$ 0.28

16% $ 98.70

$ 82.90

$ 70.47

Apply ZARVY26 (-15%)

You save $ 12.44

Product Description

Clopilet-A 75 Capsule is a fixed-dose combination of Aspirin 75 mg and Clopidogrel 75 mg, forming a dual antiplatelet therapy (DAPT) regimen for secondary prevention of cardiovascular and cerebrovascular thrombotic events. Widely prescribed for patients with a history of myocardial infarction, ischemic stroke, TIA, or peripheral artery disease, this combination provides essential synergy post-stenting and in managing acute coronary syndromes (ACS). Aspirin irreversibly inhibits COX-1, reducing thromboxane A2 and platelet aggregation, while Clopidogrel selectively blocks the ADP P2Y12 receptor, further preventing clot formation. ZarvyPharm online pharmacy offers this trusted therapy alongside other cardiovascular agents like Lipidator-A and Glucophage.

Indications & Uses

Lifestyle-related Diseases > Cerebral Infarction & Myocardial Infarction This product is used to reduce the risk of recurrent heart attacks and strokes in patients with established atherosclerotic disease. It is especially important in those who have undergone PCI or stent placement, or have experienced unstable angina, TIA, or stroke. The dual mechanism enhances platelet inhibition and minimizes thrombotic complications.

Benefits & Effectiveness

Combined antiplatelet action for enhanced cardiovascular protection
Reduces risk of stent thrombosis, myocardial infarction, and stroke
Standard of care post-PCI and in secondary prevention protocols
Effective for both coronary and cerebral arterial disease

Directions for Use

Unstable Angina (UA) / Non-ST-Elevation Myocardial Infarction (NSTEMI) - Loading Dose: 300 mg Clopidogrel orally once, Maintenance Dose: 75 mg Clopidogrel once daily, Administer concurrently with Aspirin 75–325 mg daily, Duration: Not universally defined; usually continued for 12 months post-event
ST-Elevation Myocardial Infarction (STEMI) - Loading Dose: 300 mg Clopidogrel orally once (optional), Maintenance Dose: 75 mg Clopidogrel once daily (Aspirin co-administered), Duration: Based on risk factors and physician discretion
Use - Indicated to prevent atherothrombotic events in patients with ACS (UA, NSTEMI, STEMI), Also used in patients with recent stroke or peripheral arterial disease
Cautions - Increased bleeding risk, especially with NSAIDs or anticoagulants, Avoid abrupt discontinuation in stent patients, Monitor for signs of GI bleeding, bruising, or hematoma, Not recommended in active pathological bleeding (e.g., peptic ulcer)